These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

296 related items for PubMed ID: 15194785

  • 1. Subunit-specific analysis of the human immunodeficiency virus type 1 reverse transcriptase in vivo.
    Mulky A, Sarafianos SG, Arnold E, Wu X, Kappes JC.
    J Virol; 2004 Jul; 78(13):7089-96. PubMed ID: 15194785
    [Abstract] [Full Text] [Related]

  • 2. Analysis of human immunodeficiency virus type 1 reverse transcriptase subunit structure/function in the context of infectious virions and human target cells.
    Mulky A, Kappes JC.
    Antimicrob Agents Chemother; 2005 Sep; 49(9):3762-9. PubMed ID: 16127051
    [Abstract] [Full Text] [Related]

  • 3. Identification of amino acid residues in the human immunodeficiency virus type-1 reverse transcriptase tryptophan-repeat motif that are required for subunit interaction using infectious virions.
    Mulky A, Sarafianos SG, Jia Y, Arnold E, Kappes JC.
    J Mol Biol; 2005 Jun 17; 349(4):673-84. PubMed ID: 15893326
    [Abstract] [Full Text] [Related]

  • 4. Analysis of amino acids in the beta7-beta8 loop of human immunodeficiency virus type 1 reverse transcriptase for their role in virus replication.
    Mulky A, Vu BC, Conway JA, Hughes SH, Kappes JC.
    J Mol Biol; 2007 Feb 02; 365(5):1368-78. PubMed ID: 17141805
    [Abstract] [Full Text] [Related]

  • 5. The N137 and P140 amino acids in the p51 and the P95 amino acid in the p66 subunit of human immunodeficiency virus type 1 (HIV-1) reverse transcriptase are instrumental to maintain catalytic activity and to design new classes of anti-HIV-1 drugs.
    Auwerx J, Van Nieuwenhove J, Rodríguez-Barrios F, de Castro S, Velázquez S, Ceccherini-Silberstein F, De Clercq E, Camarasa MJ, Perno CF, Gago F, Balzarini J.
    FEBS Lett; 2005 Apr 25; 579(11):2294-300. PubMed ID: 15848161
    [Abstract] [Full Text] [Related]

  • 6. Chimeric HIV-1 and feline immunodeficiency virus reverse transcriptases: critical role of the p51 subunit in the structural integrity of heterodimeric lentiviral DNA polymerases.
    Amacker M, Hübscher U.
    J Mol Biol; 1998 May 15; 278(4):757-65. PubMed ID: 9614940
    [Abstract] [Full Text] [Related]

  • 7. p66/p51 and p51/p51 recombinant forms of reverse transcriptase from human immunodeficiency virus type 1--interactions with primer tRNA(Lys3), initiation of cDNA synthesis, and effect of inhibitors.
    Dufour E, El Dirani-Diab R, Boulmé F, Fournier M, Nevinsky G, Tarrago-Litvak L, Litvak S, Andreola ML.
    Eur J Biochem; 1998 Jan 15; 251(1-2):487-95. PubMed ID: 9492322
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Analysis of HIV type 1 reverse transcriptase expression in a human cell line.
    Ansari-Lari MA, Gibbs RA.
    AIDS Res Hum Retroviruses; 1994 Sep 15; 10(9):1117-24. PubMed ID: 7530025
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Functional RT and IN incorporated into HIV-1 particles independently of the Gag/Pol precursor protein.
    Wu X, Liu H, Xiao H, Conway JA, Hunter E, Kappes JC.
    EMBO J; 1997 Aug 15; 16(16):5113-22. PubMed ID: 9305652
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Virion instability of human immunodeficiency virus type 1 reverse transcriptase (RT) mutated in the protease cleavage site between RT p51 and the RT RNase H domain.
    Abram ME, Parniak MA.
    J Virol; 2005 Sep 15; 79(18):11952-61. PubMed ID: 16140771
    [Abstract] [Full Text] [Related]

  • 14. Intramolecular chimeras of the p51 subunit between HIV-1 and FIV reverse transcriptases suggest a stabilizing function for the p66 subunit in the heterodimeric enzyme.
    Tasara T, Amacker M, Hübscher U.
    Biochemistry; 1999 Feb 02; 38(5):1633-42. PubMed ID: 9931031
    [Abstract] [Full Text] [Related]

  • 15. The β1'-β2' Motif of the RNase H Domain of Human Immunodeficiency Virus Type 1 Reverse Transcriptase Is Responsible for Conferring Open Conformation to the p66 Subunit by Displacing the Connection Domain from the Polymerase Cleft.
    Pandey AK, Dixit U, Kholodovych V, Comollo TW, Pandey VN.
    Biochemistry; 2017 Jul 11; 56(27):3434-3442. PubMed ID: 28627879
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. The amino acid Asn136 in HIV-1 reverse transcriptase (RT) maintains efficient association of both RT subunits and enables the rational design of novel RT inhibitors.
    Balzarini J, Auwerx J, Rodríguez-Barrios F, Chedad A, Farkas V, Ceccherini-Silberstein F, García-Aparicio C, Velázquez S, De Clercq E, Perno CF, Camarasa MJ, Gago F.
    Mol Pharmacol; 2005 Jul 11; 68(1):49-60. PubMed ID: 15833734
    [Abstract] [Full Text] [Related]

  • 20. HIV-1 protease dimer interface mutations that compensate for viral reverse transcriptase instability in infectious virions.
    Olivares I, Mulky A, Boross PI, Tözsér J, Kappes JC, López-Galíndez C, Menéndez-Arias L.
    J Mol Biol; 2007 Sep 14; 372(2):369-81. PubMed ID: 17651754
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 15.